Envestnet Asset Management Inc Chimerix Inc Transaction History

Envestnet Asset Management Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$0.94 - $1.23 $3,015 - $3,945	3,208 Added 7.91%	43,754 $42,000
Q2 2023 Aug 04, 2023	BUY	$1.1 - $1.54 $5,841 - $8,177	5,310 Added 15.07%	40,546 $49,000
Q1 2023 May 11, 2023	BUY	$1.19 - $2.09 $7,281 - $12,788	6,119 Added 21.02%	35,236 $44,000
Q4 2022 Feb 07, 2023	BUY	$1.67 - $2.35 $48,625 - $68,424	29,117 New	29,117 $54,000
Q1 2022 May 04, 2022	SELL	$4.58 - $6.8 $126,632 - $188,013	-27,649 Closed	0 $0
Q4 2021 Feb 04, 2022	BUY	$5.23 - $7.18 $144,604 - $198,519	27,649 New	27,649 $178,000
Q1 2021 May 04, 2021	SELL	$4.76 - $11.25 $267,183 - $631,473	-56,131 Closed	0 $0
Q4 2020 Feb 02, 2021	BUY	$2.43 - $5.42 $6,162 - $13,745	2,536 Added 4.73%	56,131 $271,000
Q3 2020 Oct 09, 2020	BUY	$2.3 - $3.72 $123,268 - $199,373	53,595 New	53,595 $133,000

37M

52.7K

130K

Ticker CMRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,622,896
Market Cap $77.1M
Description
Chimerix, Inc., a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. The company's approved product is TEMBEXA (brincidofovir), a lipid conjugate through inhibition of viral DNA synthesis that is developed as a medical countermeasure for smallpox. Its clinical stage development programs i...

Get notified when there are updates to the investment portfolio of Envestnet Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Envestnet Asset Management Inc with notifications on news.